WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/146953    International Application No.:    PCT/AT2011/000236
Publication Date: 01.12.2011 International Filing Date: 23.05.2011
C07D 303/36 (2006.01), C07C 327/30 (2006.01), C07C 211/40 (2006.01)
Applicants: NABRIVA THERAPEUTICS AG [AT/AT]; Leberstrasse 20 A-1110 Wien (AT) (For All Designated States Except US).
RIEDL, Rosemarie [AT/AT]; (AT) (For US Only).
HEILMAYER, Werner [AT/AT]; (AT) (For US Only).
SPENCE, Lee [GB/AT]; (AT) (For US Only).
BULUSU, Atchyuta, Rama, Chandra, Murty [AT/AT]; (AT) (For US Only)
Inventors: RIEDL, Rosemarie; (AT).
HEILMAYER, Werner; (AT).
SPENCE, Lee; (AT).
BULUSU, Atchyuta, Rama, Chandra, Murty; (AT)
Agent: SCHWARZ, Albin; Schwarz & Partner Wipplingerstrasse 30 A-1010 Wien (AT)
Priority Data:
10450093.9 26.05.2010 EP
Abstract: front page image
(EN)A compound of formula I wherein PROT is an amine protecting group and PROT' is hydrogen; or PROT and PROT' together with the nitrogen atom to which they are attached form a heterocyclic ring as an amine protecting group, and PROT" is a thiol protecting group, processes for its production, intermediates in their production and production of intermediates in stereoisomerically pure form, and their use for the production of pharmaceutically active compounds.
(FR)L'invention porte sur un composé de formule I dans laquelle PROT représente un groupe protecteur d'amine et PROT' est l'hydrogène, ou PROT et PROT' conjointement avec l'atome d'azote auquel ils sont attachés forment un noyau hétérocyclique en tant que groupe protecteur d'amine, et PROT" est un groupe protecteur de thiol ; sur des procédés pour sa production ; sur des intermédiaires pour sa production ; et sur la production d'intermédiaires sous forme stéréoisomériquement pure ; et sur leur utilisation pour la production de composés pharmaceutiquement actifs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)